ATAGI recommendations on use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine

Department of Health

28 February 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

The ATAGI advises that the Moderna bivalent BA.4/5 vaccine can be used in eligible adolescents and adults aged 12 years or older who are recommended (or advised to consider) a COVID-19 booster dose according to the ATAGI 2023 booster advice.

Read Department of Health News


Michael Wonder

Posted by:

Michael Wonder